Literature DB >> 29297447

Gender differences in tuberculosis diagnosis, treatment and outcomes in Victoria, Australia, 2002-2015.

K Dale1, E Tay2, J M Trauer3, P Trevan1, J Denholm4.   

Abstract

BACKGROUND: Gender has a significant impact on tuberculosis (TB) diagnosis and outcomes in many settings worldwide. We explored gender differences in Victoria, Australia, a low-incidence setting.
METHODS: Retrospective cohort study: 2002-2015. Gender was included as an independent variable in multivariate statistical analyses assessing TB management.
RESULTS: There were 2655 (54.5%) males and 2212 (45.5%) females notified (male:female ratio = 1.2:1). Among cases with pulmonary involvement, males underwent a chest X-ray or CT scan (CXR) sooner (hazard ratio [HR] 1.2, 95%CI 1.04-1.31, P = 0.010), began treatment sooner after presentation (HR 1.2, 95%CI 1.08-1.34, P = 0.001) and were more likely to have a sputum smear sample performed (OR 1.3, 95%CI 1.01-1.55, P = 0.037). Male cases with extra-pulmonary TB sought health care sooner after symptom onset (HR 1.3, 95%CI 1.03-1.58, P = 0.024) and were more likely to have an abnormal CXR (OR 1.9, 95%CI 1.54-2.32, P < 0.001). Males were more likely to die before or during treatment (OR 1.5, 95%CI 1.06-2.11, P = 0.024).
CONCLUSIONS: Women experienced small delays in management compared with men, with no obvious detriment to assessment results or treatment outcomes. Differences were consistent with the hypothesis that males manifest more severe disease at presentation, which could be related to a range of biological and social factors.

Entities:  

Mesh:

Year:  2017        PMID: 29297447     DOI: 10.5588/ijtld.17.0338

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

Review 1.  Sex and Gender Differences in Bacterial Infections.

Authors:  Sara P Dias; Matthijs C Brouwer; Diederik van de Beek
Journal:  Infect Immun       Date:  2022-09-19       Impact factor: 3.609

2.  Delayed Tuberculosis Treatment and Cost of Care in a Low-Incidence Country.

Authors:  James O'Connell; Niamh Reidy; Cora McNally; Eoghan de Barra; Debbi Stanistreet; Samuel McConkey
Journal:  Open Forum Infect Dis       Date:  2022-04-02       Impact factor: 4.423

3.  Gender Differences in Factors Associated with the Total Delay in Treatment of Pulmonary Tuberculosis Patients: A Cross-Sectional Study in Selangor, Malaysia.

Authors:  Kee Chee Cheong; Sumarni Mohd Ghazali; Ahmed Syahmi Syafiq Md Zamri; Yoon Ling Cheong; Nuur Hafizah Md Iderus; Tharmarajah Nagalingam; Qistina Ruslan; Mohd Azahadi Omar; Ahmad Faudzi Yusoff
Journal:  Int J Environ Res Public Health       Date:  2022-05-21       Impact factor: 4.614

4.  Male Sex Is Associated With Worse Microbiological and Clinical Outcomes Following Tuberculosis Treatment: A Retrospective Cohort Study, a Systematic Review of the Literature, and Meta-analysis.

Authors:  Vignesh Chidambaram; Nyan Lynn Tun; Marie Gilbert Majella; Jennie Ruelas Castillo; Samuel K Ayeh; Amudha Kumar; Pranita Neupane; Ranjith Kumar Sivakumar; Ei Phyo Win; Enoch J Abbey; Siqing Wang; Alyssa Zimmerman; Jaime Blanck; Akshay Gupte; Jann-Yuan Wang; Petros C Karakousis
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 20.999

5.  Patient predictors of poor drug sensitive tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.

Authors:  Omowunmi Aibana; Andrej Slavuckij; Mariya Bachmaha; Viatcheslav Krasiuk; Natasha Rybak; Timothy P Flanigan; Vasyl Petrenko; Megan B Murray
Journal:  F1000Res       Date:  2017-10-23

6.  Recurrent tuberculosis in the Netherlands - a 24-year follow-up study, 1993 to 2016.

Authors:  Connie Erkens; Betül Tekeli; Dick van Soolingen; Henrieke Schimmel; Suzanne Verver
Journal:  Euro Surveill       Date:  2022-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.